Prima BioMed Ltd, a world leader in cancer immunotherapies, will visit the NASDAQ MarketSite in
Prima's listing on NASDAQ comes at a significant point in the development timeline for CVac™ ovarian cancer vaccine. The timing should offer U.S, investors an opportunity to share in this growth phase of the Company.
In honor of the occasion,
NASDAQ MarketSite —
+61 9276 1250
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:
For news tweets, please visit our Twitter page at:
A live webcast of the NASDAQ Opening Bell will be available at:
To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.
About Prima BioMed Ltd:
Prima BioMed is an ASX and NASDAQ listed Australian health care company. The Company is focused on technologies in the fields of cancer immunotherapy and immunology.
Prima's lead product is the CVacTM ovarian cancer therapy treatment. It has completed two successful clinical trials and is progressing toward eventual commercialisation in
The Company's broader, long term goal is to develop commercial cancer treatment technologies and programs for global markets.
The inventor of the electronic exchange,
News Provided by Acquire Media